Skip to search.
 STI Down 0.21%

Merck & Co. Inc. (MRK)

-NYSE
57.89 Down 0.45(0.77%) 02:08 SGT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:58.34
Open:58.19
Bid:57.88 x 2000
Ask:57.89 x 200
1y Target Est:63.77
Beta:0.43
Next Earnings Date:28-Apr-15MRK Earnings announcement
Day's Range:57.81 - 58.31
52wk Range:52.49 - 63.62
Volume:4,715,929
Avg Vol (3m):11,433,200
Market Cap:164.30B
P/E (ttm):14.22
EPS (ttm):4.07
Div & Yield:1.80 (3.10%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MRKDown 0.77%164.30B
GSKDown 2.03%111.23B
NVSDown 2.36%237.27B
PFEUp 0.27%215.09B

Key Statistics

Forward P/E (1 yr):15.19
P/S (ttm):3.92
Ex-Dividend Date:12-Mar-15

Analysts

Annual EPS Est (Dec-15) :3.38
Quarterly EPS Est (Mar-15) :0.75
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):3.60

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infec... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback